We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Final GDUFA Guidance Clarifies Penalties for Unpaid User Fees
Final GDUFA Guidance Clarifies Penalties for Unpaid User Fees
Generics makers that do not pay user fees on time will be charged penalties and interest, the FDA said in a final Q&A guidance on GDUFA I, the generics user free agreement that expires on Sept. 30, 2017.